The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately. The price has held steady around $1.13 per unit over the past year. One of its named manufacturing plants, Eugia Pharma Specialities Limited, failed FDA inspectionwithin the last two years — the agency’s most serious outcome. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.